We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
Launch of BeST cluster OneHealth Bengaluru City Consortium
On 3rd March 2023, over 30 organisations in Bengaluru came together focusing... read more
Anti-microbial resistance – The next pandemic
“Although the link between human anti-microbial use and emergence of resistance is... read more
Get your hands dirty: Sewage surveillance is critical for public health in India – Article in Hindustan Times
TIGS in the News This recent article highlights the need to integrate Sewage... read more
Student visit – St. Joesph’s College, Bengaluru
A day well spent! On the occasion of National Science Day and Rare... read more
IMPACT 2025: A Year of Strengthening India’s Clinical Wastewater Surveillance Network
We are pleased to close the year with the successful completion of... read more
Detailed genome map of malaria vector
Scientists have unveiled the detailed genome of the malaria mosquito vector, revealing... read more
Launch of BeST Cluster
Bengaluru Science and Technology (BeST) Cluster launched at the Bengaluru Tech Summit... read more
Health expert calls for reducing booster dose gap from 9 to 6 months
Director of Tata Institute for Genetics and Society (TIGS), Bengaluru, Dr Rakesh... read more
REDRESS 2025: A Two-Day Convergence on Rare Genetic Diseases
Click here for REDRESS 2025 meeting proceedings The 4th Rare Genetic Diseases Research... read more
‘Pandemic is not yet over….’
Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the... read more

